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Myosin II Isoforms in DurotaxisA new study reveals that non-muscle myosin II plays a central role in the
durotaxis of mesenchymal stem cells, with the two major isoforms, II-A and
II-B, being cooperatively required for this cell movement, and serine
phosphorylation of the II-A isoform playing a negative role.Miguel Vicente-Manzanares
Durotaxis is the tendency of most cells
to move towards stiffer substrates
when they are migrating on
a compliance gradient. This type of
movement is a cellular behavior
based on the mechanical, rather
than biochemical, properties of its
microenvironment; thus, it can be
classified as a process involving
mechanotransduction. The
physiological relevance of this poorly
studied form of migration is beginning
to be elucidated, and the ramifications
are fascinating. Tissue stiffness favors
tumorigenesis [1] as well as cell
proliferation [2]. Furthermore, cells
spread and migrate more easily on stiff
than on compliant substrates [3].
What mediates durotaxis is not well
characterized, but major players
include integrins and focal adhesion
kinase (FAK) [3,4]. Now, based on
a new study from Raab and co-workers
[5], we can add non-muscle myosin II
(NMII) to the list of durotaxis mediators.
While studied extensively in the 80s
and 90s, NMII has come back into
the spotlight more recently due to
its pivotal roles in various crucial
cellular phenomena, for example,
cell migration, division, differentiation
and apoptosis (reviewed in [6]).
By controlling these processes,
NMII is a major integrator of the
mechanical properties of the cellular
microenvironment, controlling stem
cell differentiation and morphology[7,8], tumorigenesis [9], and cell
migration [10].
The relatively simple vision of NMII
as a contraction- or force-generating
device was complicated by the
identification of three major isoforms
of the heavy chain and their splice
variants, the elucidation of different
regulatory sites within the light and
heavy chains, and the description
of several regulatory kinases and
phosphatases that control the
contractile, ATPase-based activity
of NMII. This picture is even more
complex taking into account the fact
that, despite their apparent inability to
heterodimerize, the different isoforms
of NMII cooperate to mediate their
biological roles.
In most mammalian cells, there
are two major NMII isoforms, which
are defined by the nature of the
actin-binding, ATPase myosin heavy
chain: NMII-A and NMII-B (a third
isoform, NMII-C, does exist, but its
expression is more restricted, hence
its biological significance on a broad
context is not yet clear). Both isoforms
are implicated in cell migration, but
their inhibition produces separable
outcomes. NMII-A is implicated in
cortical stability [11] and retraction
of the cell rear [12], whereas NMII-B
is required for cells to polarize and
migrate directionally [12,13]. The role
of the NMII isoforms in the control of
cell shape reflects their subcellular
positioning: whereas NMII-A is
homogenously distributed andlocalizes everywhere in the cell but
the lamellipodium, NMII-B is more
confined to the central and rear
portions of the cell [14], defining the
rear by segregating protrusive signals
away from these regions [15,16].
However, an interplay between
these isoforms exists because in
NMII-A-deficient cells NMII-B is not
confined to the central and rear parts
of the cell but appears homogeneously
distributed and seldom assembles
into mini-filaments [15].
Raab et al. [5] now show that NMII-A
and NMII-B mediate durotaxis of
mesenchymal stem cells. They first
demonstrate that NMII-B localizes
to the center and rear of primary
mesenchymal stem cells on stiff
substrates, defining a non-protrusive
region. Conversely, on more compliant
surfaces, NMII-B is not polarized.
On either substrate, NMII-A remains
evenly distributed, although its
assembly into mini-filaments increases
as substrates become stiffer. The
authors then probed which of the
isoforms played a more prominent
role in the control of durotaxis.
siRNA-induced inhibition proved
that a small reduction in NMII-B was
sufficient to impair durotaxis, whereas
only a large knockdown of NMII-A
produced the same effect. This led the
authors to conclude that, although both
isoforms are implicated in durotaxis,
NMII-B is a more sensitive part of the
molecular mechanism that controls it.
To try to explain the differential
sensitivity to depletion of each NMII
isoform in controlling durotaxis, the
authors studied the dependence of
the dynamics of both isoforms on the
compliance of the substrate. They
noticed that NMII-A was more dynamic
(which is a proxy for decreased affinity
of NMII-A for stable actomyosin
filaments) in cells on soft compared to










Figure 1. Rigidity correlates directly with
NMII-A assembly, NMII-B rearward localiza-
tion and cell polarization, and inversely with
NMII-A phosphorylation on Ser1943.
Cells tend to move from compliant to stiff
substrates via durotaxis. Stiff substrates
promote the non-polarized assembly of
NMII-A (red) into mini-filaments, which are
necessary for NMII-B assembly and polariza-
tion. Conversely, soft substrates do not sup-
port NMII-A assembly nor NMII-B assembly/
polarization. Soft substrates promote NMII-A
phosphorylation on Ser1943, which may
constitute a mechanism to inhibit the forma-
tion of large filaments.
Dispatch
R29increased phosphorylation of NMII-A
on Ser1943: phosphorylation at this site
has previously been reported to inhibit
NMII-A assembly and stability [17]. The
authors observed that there was an
inverse correlation between substrate
stiffness and Ser1943 phosphorylation,
and that dephosphorylation of Ser1943
of NMII-A was required for proper
NMII-B polarization on stiff substrates,
suggesting that Ser1943
phosphorylation/dephosphorylation
is a mechanosensitive signal that
responds to changes in the pliability
of the substrate.
These findings are summarized in
Figure 1. Soft substrata prevent cell
polarization and NMII-A assembly into
large filaments and bundles, at least
partially as a result of high levels of
Ser1943 phosphorylation. Conversely,
stiffer substrates decrease Ser1943
phosphorylation and promote NMII-A
assembly and NMII-B assembly and
polarization. The data presented in this
study confirm that phosphorylation of
NMII-A on Ser1943 negatively regulates
NMII-A assembly. This work also
postulates that the kinase that
phosphorylates Ser1943 (possibly
casein kinase II) responds to changes
in the compliance of the substratum,
i.e. is mechanoresponsive, and may be
more active at low compliance than
at high compliance. Another possibilityis that a Ser1943 phosphatase is
activated by stiff substrates. For
example, protein phosphatase 2A
(PP2A) is a broad-specificity serine
phosphatase that interacts with
p130CAS [18], an adaptor protein that
is phosphorylated and activated by Src
in response to molecular stretching
[19]. A possible model is that activation
of p130CAS by substrate stiffness
recruits PP2A, which would in turn
dephosphorylate NMII-A, promoting its
assembly.
The data in this study clearly show
that the assembly of NMII-A is required
for the polarization of NMII-B. It has
been suggested that NMII-A generates
physical ‘templates’ that mediate the
initial accumulation of NMII-B in
discrete regions of the cell [15]. This
study suggests that stiff substrates
promote the assembly of NMII-A into
myosin mini-filaments of sufficient size
to nucleate NMII-B bundling.
Conversely, more compliant substrates
do not support assembly of NMII-A
mini-filaments of sufficient size to serve
as scaffolds for NMII-B.
The implications of this study for
stem cell biology are also important.
Most attempts to graft mesenchymal
stem cells directly into tissues to
promote regeneration in situ have
failed, mainly because of the inability
of these stem cells to migrate and/or
differentiate into target cells. The study
byRaabet al. [5] implies that these stem
cells use NMII-A andNMII-B to adapt to
the mechanical properties of their
surroundings and promote migration
towards stiffer microenvironments. The
manipulation of the expression and/or
activation of the non-muscle myosin II
expressed bymesenchymal stem cells,
or of the mechanical properties of the
target tissue, might therefore be
avenues worth exploring in the design
of new strategies aimed at improving
the migration of mesenchymal stem
cells in therapy.References
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